Skip to Content
Merck
  • Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine.

Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine.

Journal of the American Society of Nephrology : JASN (1994-08-01)
D S Alejandro, J Petersen
ABSTRACT

Acute renal failure can occur in cardiac transplant patients for a variety of reasons. A case of a patient who developed acute renal failure secondarily to drug-induced rhabdomyolysis is reported. The literature regarding acute renal failure and lovastatin and other 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors is reviewed. The potential mechanisms of myoglobinuria and nephrotoxicity and the therapeutic implications are discussed.

MATERIALS
Product Number
Brand
Product Description

Lovastatin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Mevinolin from Aspergillus sp., ≥98% (HPLC)
USP
Lovastatin, United States Pharmacopeia (USP) Reference Standard
Supelco
Lovastatin, Pharmaceutical Secondary Standard; Certified Reference Material
Lovastatin for peak identification, European Pharmacopoeia (EP) Reference Standard